Al-`Aqar Healthcare REIT ("Al-`Aqar) (5116) Fair Value & Analysis
Real Estate · MY · Market cap 974M MYR
Fair value as of: Jul 12, 2026
From 12 valuation models · updated 29 days ago
A solid business, but screening 20% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (1.08 MYR). The favourable scenario is already priced in.
- Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder.
- As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.
How to read this chart
60‑month range 0.8999 MYR – 1.29 MYR · fair‑value band 0.7000 MYR – 1.08 MYR · the 1.16 MYR price screens above the 0.9300 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 12, 2026.
Analysis
Al-`Aqar Healthcare REIT ("Al-`Aqar) (5116) currently trades at 1.16 MYR, while our model-based Fair Value estimate is 0.9300 MYR, implying the stock looks roughly 19.8% overvalued today. The Quality Score stands at 60/100 (solid quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Al-`Aqar Healthcare REIT ("Al-`Aqar) generated revenue of 124M MYR at a net margin of 46.1%. Revenue grew 13.0% year over year. It earns a return on equity of 5.4%. Net debt stands at 970M MYR. Fundamentals as of Jul 12, 2026
Our scenario range runs from 0.7000 MYR (bear case) to 1.08 MYR (bull case); at 1.16 MYR, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 10% below its 52-week high, currently below its 200-day average. For context, the median of 10 Real Estate peers we cover trades at -53% fair-value upside, at -20%, 5116 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 12 models by family
Widest divergence: Growth DCF (0.9900 MYR) versus Dividend Discount (0.6300 MYR). Highest evidence: Growth DCF (80).
Notify me when 5116 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 58 · Market factors (momentum, volatility) 55
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Al-`Aqar Healthcare REIT ("Al-`Aqar) is listed on the main market of Bursa Malaysia. From its humble beginnings with a portfolio of just six properties, Al-`Aqar has steadily evolved and transformed into a reputable player in the Malaysian REIT landscape.
Full company description
Al-`Aqar Healthcare REIT ("Al-`Aqar) is listed on the main market of Bursa Malaysia. From its humble beginnings with a portfolio of just six properties, Al-`Aqar has steadily evolved and transformed into a reputable player in the Malaysian REIT landscape. Today, it boasts an extensive portfolio of 23 properties strategically diversified across several key segments, with a notable focus on healthcare assets. The portfolio now comprises 17 hospitals, three wellness/ health centers, two colleges, and an aged care facility, underscoring Al-`Aqar's robust position in the healthcare real estate sector. This diverse mix of properties not only highlights the fund's adaptability but also its ability to cater to the growing demand for specialized healthcare and wellness services in Malaysia. Al-`Aqar's growth trajectory has been driven by the expertise and strong leadership of JLG REIT Managers Sdn Bhd (JRM) (formerly known as Damansara REIT Managers Sdn Berhad), which serves as the fund manager. JRM is a wholly owned subsidiary of Johor Corporation and is further supported by KPJ Healthcare Berhad (KPJ), both of which provide a solid foundation for Al-`Aqar's strategic direction and operational success. JRM's dedicated efforts in asset management, operational efficiency, and portfolio optimization have been instrumental in the fund's continued success and expansion. As of 31 December 2024, Al-`Aqar's portfolio is valued at RM1.65 billion, with a market capitalization of RM1.14 billion. Al-'Aqar Healthcare REIT was incorporated in 2006 in Malaysia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Al-`Aqar Healthcare REIT ("Al-`Aqar) reported revenue of 120M MYR in FY2025 versus 114M MYR in FY2021, a compound +1.3%/yr. Reported net income was 55.7M MYR in FY2025, compounding −6.7%/yr from FY2021.
5116 screens 20% overvalued. Compare with Welltower Inc →
Peer Group
REIT - Healthcare Facilities · 28 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs REIT - Healthcare Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more REIT - Healthcare Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Welltower Inc WELL | $231.59 | $42.21 | -82% |
| Ventas, Inc VTR | $100.53 | $18.07 | -82% |
| Omega Healthcare Investors, Inc OHI | $47.39 | $33.54 | -29% |
| Healthpeak Properties, Inc DOC | $22.27 | $7.02 | -68% |
| American Healthcare REIT, Inc AHR | $56.38 | $11.04 | -80% |
| CareTrust REIT, Inc CTRE | $43.25 | $23.07 | -47% |
| Healthcare Realty Trust Incorporated HR | $21.40 | $20.60 | -4% |
| Aedifica NV AED | €69.85 | €36.17 | -48% |
| Chartwell Retirement Residences CSHUN | C$22.81 | C$3.52 | -85% |
| Sabra Health Care REIT, Inc SBRA | $22.36 | $10.49 | -53% |
Compare Al-`Aqar Healthcare REIT ("Al-`Aqar) with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Real Estate stocks →
Frequently asked questions
Is Al-`Aqar Healthcare REIT ("Al-`Aqar) (5116) overvalued or undervalued?
What is the fair value of 5116?
What is the quality score of 5116?
What is the revenue of Al-`Aqar Healthcare REIT ("Al-`Aqar) (5116)?
What is the net profit margin of 5116?
Does Al-`Aqar Healthcare REIT ("Al-`Aqar) pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Al-`Aqar Healthcare REIT ("Al-`Aqar) and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.